Orsi Fernanda Andrade, De Paula Erich V, Santos Fernanda de Oliveira, Teruchkin Marcelo Melzer, Campêlo Dirceu Hamilton Cordeiro, Mello Tayana Teixeira, Chindamo Maria Chiara, Macedo Ariane Vieira Scarlatelli, Rocha Ana Thereza, Ramacciotti Eduardo, Nascimento Ana Clara Kneese, Annichino-Bizzacchi Joyce, Lourenco Dayse Maria, Guerra João Carlos de Campos, Rezende Suely Meireles, Cavalheiro Filho Cyrillo
Faculdade de Ciências Médicas da Universidade Estadual de Campinas (FCM-Unicamp), Campinas, SP, Brazil.
Centro de Hematologia e Hemoterapia da Universidade Estadual de Campinas (Hemocentro-Unicamp), Campinas, SP, Brazil.
Hematol Transfus Cell Ther. 2020 Oct-Dec;42(4):300-308. doi: 10.1016/j.htct.2020.06.001. Epub 2020 Jun 13.
Hemostatic abnormalities and thrombotic risk associated with coronavirus disease 2019 (COVID-19) are among the most discussed topics in the management of this disease. The aim of this position paper is to provide the opinion of Brazilian experts on the thromboprophylaxis and management of thrombotic events in patients with suspected COVID-19, in the sphere of healthcare in Brazil. To do so, the Brazilian Society of Thrombosis and Hemostasis (BSTH) and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) have constituted a panel of experts to carefully review and discuss the available evidence about this topic. The data discussed in this document was reviewed by May 9, 2020. Recommendations and suggestions reflect the opinion of the panel and should be reviewed periodically as new evidence emerges.
2019冠状病毒病（COVID-19）相关的止血异常和血栓形成风险是该疾病管理中讨论最多的话题之一。本立场文件的目的是在巴西医疗保健领域，提供巴西专家对疑似COVID-19患者血栓预防和血栓形成事件管理的意见。为此，巴西血栓与止血学会（BSTH）和巴西血液学、血液治疗与细胞治疗协会（ABHH）的血栓与止血委员会组建了一个专家小组，以仔细审查和讨论关于该主题的现有证据。本文档中讨论的数据截至2020年5月9日进行了审查。建议和意见反映了专家小组的观点，应随着新证据的出现定期进行审查。
